Fructo-oligosaccharide
Short-chain, mildly sweet prebiotic fibers made of fructose units (often called FOS/scFOS). They add bulk and fiber, lightly sweeten, and help retain moisture (draws and holds water, i.e., humectant).
Should I eat Fructo-oligosaccharide?
A highly refined, enzyme‑produced prebiotic fiber that can support a healthier gut microbiome. If you’re FODMAP‑sensitive or the serving is large, keep single doses small and space them out to avoid bloating.
Summary
Fructo‑oligosaccharide (FOS) is a short‑chain soluble fiber found in chicory and also made from sucrose with food enzymes, then purified to syrups or powders. It feeds beneficial gut bacteria and increases short‑chain fatty acids, a sign of prebiotic activity. Safety has been evaluated across multiple FDA GRAS notices, while EFSA has not authorized a specific bowel‑regularity claim—so effects differ by person and dose. Digestive symptoms rise with larger single servings; ramp up slowly and split intake during the day. Infant formula uses are tightly limited by age; adults with IBS should test cautiously.
Key Research Points
Overview
What is it?
Why is it used?
Origin
Plants like chicory, Jerusalem artichoke, and agave naturally stockpile inulin-type fructans. In the late 20th century, Japanese and European producers popularized purified, short-chain versions—‘fructo-oligosaccharides’—as an easy-to-use fiber and partial sugar replacer in mainstream foods. Today, FOS is either trimmed from longer plant fructans (inulin) or built directly from sucrose with food enzymes, then purified to syrups or powders for use in foods worldwide.
Process: Enzymatic transfructosylation and polishing
Steps
Chemicals
Research & Safety
Potential Concerns
The main concern is digestive discomfort when too much is consumed at once—gas, bloating, and softer stools become more likely with larger single servings. Evidence suggests many healthy adults tolerate typical daily amounts, but sensitive individuals may react at lower doses. In the EU, regulators have not authorized certain health claims (e.g., maintaining normal defecation), so consumers should be wary of overly strong marketing language. For infants, specific formula limits apply and should not be exceeded.
Potential Benefits
FOS act as prebiotic fibers that selectively nourish beneficial gut microbes, especially bifidobacteria, and support production of short‑chain fatty acids linked with gut health. Because they are highly soluble and only mildly sweet, they can add fiber without strong taste or texture changes, and can partially replace sugar in some foods. Some people also notice softer stools with regular intake, but this is not guaranteed and depends on dose and individual response. Overall, FOS help manufacturers fortify foods with fiber while offering genuine, though modest, microbiome benefits.
Digestive Effects
Tolerance improves when intake is increased gradually and spread through the day. GRAS contexts commonly frame around 20 g/day for general use, and one study in healthy adults reported acceptable tolerance up to ~40 g/day, though mild GI symptoms rose with dose. Many products target 10–15 g/day to balance benefits and comfort. People with IBS or high‑FODMAP sensitivity are more likely to experience symptoms at lower doses and should titrate slowly.
Limit Consumption
Term infant formulas have explicit FOS limits—400 mg/100 mL from 0–6 months and 500 mg/100 mL thereafter—and these should be followed carefully. Individuals with IBS or FODMAP sensitivity may need lower doses or alternative fibers due to higher symptom risk. FOS are not among the U.S. major allergens and are plant‑derived, which suits vegan and dairy‑free diets. Regulatory reviews report no genotoxicity and no treatment‑related systemic toxicity at tested doses in animals, supporting general safety.
Fact Sheet
Regulatory Status
ESG & Sustainability
Allergens and Diet
Natural Alternatives
Dates
Inulin
Galacto-oligosaccharides
Citations
GRN 000044 – Fructooligosaccharide
2000-05-02GTC Nutrition Company • FDA GRAS Notice Inventory
GRAS Notice 000605 – Fructo-oligosaccharides
2016-01-01Tata Chemicals Ltd.; Expert Panel • FDA
GRAS Notice 000623 – Fructooligosaccharides
2016-01-20Ingredion Incorporated; Expert Panel • FDA
GRAS Notice 000717 – Short-chain fructo-oligosaccharides
2017-06-13Galam Ltd.; Expert Panel • FDA
GRAS Notice 001006 – Short-chain fructooligosaccharides (Ingredion)
2021-12-16Keller and Heckman LLP on behalf of Ingredion • FDA
GRN 000797 – Fructooligosaccharides (Infant Formula)
2019-01-01New Francisco (Yunfu City) Biotechnology Corp. • FDA GRAS Notice Inventory
Short-chain FOS from sucrose and normal defecation
2016-01-08EFSA NDA Panel • EFSA Journal
The Prebiotic Potential of Inulin-Type Fructans
2021-03-28R.L. Hughes, M.C. Holscher • Nutrients
Gastrointestinal Tolerance of Short-Chain FOS
2022-04-11C. Le Bourgot, C. Apper, C. Blanquet-Diot, et al. • Nutrients
Fructooligosaccharides – Technical Review (National List context)
2015-01-20USDA Agricultural Marketing Service • USDA AMS